PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 20, 2024Medicine4 citationsOpen Access

Efficacy of N-acetylcysteine in reducing inflammation and oxidative stress to prevent complex regional pain syndrome type 1

View Full Paper
MDMustafa DinçÖSÖmer Cevdet Soydemir

Key Points

Key points are not available for this paper at this time.

Abstract

This study aimed to evaluate the effectiveness of N-acetylcysteine (NAC) in preventing complex regional pain syndrome type 1 (CRPS-1) by reducing proinflammatory cytokines and oxidative stress markers in patients with distal radius fractures. A retrospective single-center study at Bursa City Hospital involves patients over 50 years of age with distal radius fractures treated between January 2021 and December 2023. A total of 60 patients (mean age, 62.8 ± 5.1 years; 26 males and 34 females) were analyzed. Patients were divided into 2 groups: the NAC group (31 patients receiving 600-mg NAC daily for 3 months) and the control group (29 patients with no prophylactic medication). CRPS-1 diagnosis was based on Budapest criteria during multiple follow-up visits. Serum levels of interleukin (IL)-1 beta, IL-6, tumor necrosis factor-alpha (TNF-α), total oxidant status (TOS), and total antioxidant status (TAS) were measured at baseline and study end point. CRPS-1 positive patients had significantly higher levels of IL-6, TNF-α, and IL-1 (P < .001 for all), higher TOS (P < .001) and oxidative stress index (P < .001), and lower TAS (P < .001) compared with CRPS-1 negatives. The incidence of CRPS-1 was significantly lower in the NAC group (9.7%) compared with the control group (31.0%; P = .039). Logistic regression indicated a 78% reduction in CRPS-1 odds ratio with NAC treatment (odds ratio, 0.219 95% confidence interval, 0.053-0.895; P = .0322). NAC significantly reduced end-point levels and changes in IL-6 (P < .001), TNF-α (P < .001), and IL-1 (P = .038) and improved oxidative stress markers, showing higher TAS (P < .001), lower TOS (P < .001), and oxidative stress index (P < .001) compared with controls. NAC significantly reduced the risk of developing CRPS-1 by decreasing levels of proinflammatory cytokines and oxidative stress. This study highlights NAC's potential as a preventive treatment for CRPS-1 and emphasizes the importance of early intervention.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Dinç et al. (2024) studied this question.

synapsesocial.com/papers/68e57c2ab6db64358751ba6chttps://doi.org/10.1097/md.0000000000039742
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Vitamin C in Complex Regional Pain Syndrome in Patients with Distal Radius Fracture.2025
  2. 2[Vitamin C in Complex Regional Pain Syndrome in Patients with Distal Radius Fracture].2025
  3. 3Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis2009 · 97 citations
  4. 4Protective Effects of N-Acetylcysteine Against Acrylamide-Induced Lung Toxicity via Regulation of GSK-3β/Nrf2/NF-κB Signaling: Molecular and Immunohistochemical Evidence2026
  5. 5High-dose <i>N</i> -acetyl cysteine reduces GFAP levels: Exploratory results from a pilot double-blind, placebo-controlled randomized trial2026